Jj. Vargo et al., Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series, GASTROIN EN, 52(2), 2000, pp. 250-255
Background: Traditional methods of sedation and analgesia for advanced endo
scopic procedures can be inadequate and frequently prolong recovery room ob
servation. Propofol is a rapidly acting agent that produces an excellent hy
pnotic state, but its use is typically limited to anesthesiologist-assisted
cases because of the inadequacy of current monitoring standards to reliabl
y detect early stages of respiratory depression.
Methods: Ten patients undergoing advanced upper endoscopic procedures (endo
scopic retrograde cholangiopancreatography, endoscopic ultrasound, esophage
al stent placement) received a propofol infusion under the control of a sec
ond qualified gastroenterologist with advanced cardiac life support skills.
Graphic assessment of respiratory activity was made by using a sidestream
carbon dioxide detecting cannula. Patient satisfaction was measured with a
100 mm visual analog scale. Recovery scores were measured by standardized s
coring of discharge criteria.
Results: Monitoring with graphic assessment of respiratory activity detecte
d early phases of respiratory depression, resulting in a timely decrease in
the propofol infusion without significant hypoxemia, hypercapnia, hypotens
ion, or arrhythmias. Satisfaction scores were extremely high (median score
92 of 100) and 9 of 10 patients met discharge criteria at 15 minutes after
discontinuation of the propofol infusion.
Conclusions: With the use of monitoring by graphic assessment of respirator
y activity, propofol infusion by a second qualified gastroenterologist for
prolonged upper endoscopic procedures is safe and results in high levels of
patient satisfaction with rapid recovery times.